CASQ2 and catecholaminergic polymorphic ventricular tachycardia: We first showed that flecainide decreased arrhythmias in two drug-refractory patients and also in Casq2-knockout (Casq2−/−) mice, a CPVT model (Watanabe et al., 2009).